Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jaffee, US
Alan Jaffee, Bowling Green, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20100167005 | DIRECTLY DECORATABLE COMPOSITE MATERIALS, METHOD FOR THEIR MANUFACTURE AND THEIR USE - The invention relates to directly decoratable and/or printable composite materials suitable in particular as materials in interior finishing, for linings, constructions and for the manufacture of furniture and similar products. | 07-01-2010 |
| 20100221973 | COMPOSITE MATERIALS, METHOD FOR THEIR MANUFACTURE AND THEIR USE - The invention relates to the manufacture of new composite materials suitable in particular as materials in interior construction, for linings, constructions and for the manufacture of furniture and similar products. | 09-02-2010 |
Alan Michael Jaffee, Bowling Green, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20090173423 | Gypsum board faced with non-woven glass fiber mat - A gypsum board comprises a set gypsum layer having a first face and a second face. A fibrous mat is affixed to at least one of the faces. The mat comprises a non-woven web bonded together with a resinous binder. The web is composed of chopped continuous glass fibers having an average fiber diameter ranging from about 9.5 to 12.5 μm. The board is exceedingly durable. It has a smooth surface that is readily finished in an aesthetically pleasing way, using paint or other wall covering systems. | 07-09-2009 |
| 20100031619 | Filter media including silicone and/or wax additive(s) - A method of improving filtration efficiency of a fibrous nonwoven filter media comprises providing a filter media and incorporating in the filter media one or more additives selected from the group consisting of silicone additives, wax additives, and mixtures thereof. The filter media comprises glass fibers, polymer fibers, and optionally binder. Inclusion of silicone and/or wax additive(s) in a filter media has surprisingly been found to increase filtration efficiency, for example, by 10-15%. | 02-11-2010 |
| 20100273376 | FIBER GLASS MAT, METHOD AND LAMINATE - Alkaline resistant fibrous products containing a binder comprised of a blend of urea formaldehyde and melamine formaldehyde and having particular use in bonding to alkaline materials having a pH of about 8 or above, including cementitious boards and other shapes, to provide manufacturing aids, reinforcement, fire resistance and a smooth surface are disclosed. Laminates containing one or more of the alkaline resistant fibrous products, with fibers bonded together with melamine formaldehyde and optionally a blend of urea formaldehyde and melamine formaldehyde binder, in contact with at least one cementitious layer are disclosed. Also, methods of making the alkaline resistant fibrous products and laminates that contain one or more layers of the alkaline resistant fibrous products are disclosed. | 10-28-2010 |
| 20110171538 | GLASS-FIBER CONTAINING COMPOSITE MATERIALS FOR ALKALI METAL-BASED BATTERIES AND METHODS OF MAKING - Glass-fiber composites are described that include a substrate containing glass fibers and particles in contact with the glass fiber substrate. The particles may include an alkali-metal containing compound. In addition, batteries are described with an anode, a cathode, and an electrolyte. The cathode may include alkali-metal containing nanoparticles in contact with glass fibers. Also describe are methods of making a glass-fiber composite. The methods may include the steps of forming a wet laid non-woven glass fiber substrate, and contacting alkali-metal containing particles on the substrate. | 07-14-2011 |
| 20120321807 | METHOD OF MAKING TOUGH, FLEXIBLE MATS AND TOUGH, FLEXIBLE MATS - Methods of making nonwoven mats having good strength after being scored and folded and particularly useful in making lightweight, compressible ceiling panels are disclosed. The mats also have excellent flame resistance. The mats include a blend comprising a major portion of glass fibers and a minor portion of man-made polymer fibers, the fibers being bound together with a cured binder containing a homopolymer or copolymer of polyacrylic acid and a polyol. The binder bonding the mat together can be cured to only a “B” stage to produce thermoformable mats or more fully cured to produce mats having the properties described above. | 12-20-2012 |
Dan Jaffee, Michigan City, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20120318205 | CAT LITTER PRODUCT - Litter compositions are provided comprising sodium bentonite and various fillers. These litter compositions have substantially the same clumpability properties as a composition consisting of only the sodium bentonite. | 12-20-2012 |
Elizabeth Jaffee, Lutherville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090110702 | Mesothelin Vaccines and Model Systems and Control of Tumors - Mesothelin can be used as an immunotherapeutic target. It induces a cytolytic T cell response. Portions of mesothelin which induce such responses are identified. Vaccines can be either polynucleotide- or polypeptide-based. Carriers for raising a cytolytic T cell response include bacteria and viruses. A mouse model for testing vaccines and other anti-tumor therapeutics and prophylactics comprises a strongly mesothelin-expressing, transformed peritoneal cell line. | 04-30-2009 |
| 20090165152 | Mesothelin Vaccines and Model Systems - Mesothelin can be used as an immunotherapeutic target. It induces a cytolytic T cell response. Portions of mesothelin which induce such responses are identified. Vaccines can be either polynucleotide- or polypeptide-based. Carriers for raising a cytolytic T cell response include bacteria and viruses. A mouse model for testing vaccines and other anti-tumor therapeutics and prophylactics comprises a strongly mesothelin-expressing, transformed peritoneal cell line. | 06-25-2009 |
| 20120076752 | Mesothelin Vaccines and Model Systems - Mesothelin can be used as an immunotherapeutic target. It induces a cytolytic T cell response. Portions of mesothelin which induce such responses are identified. Vaccines can be either polynucleotide- or polypeptide-based. Carriers for raising a cytolytic T cell response include bacteria and viruses. A mouse model for testing vaccines and other anti-tumor therapeutics and prophylactics comprises a strongly mesothelin-expressing, transformed peritoneal cell line. | 03-29-2012 |
Elizabeth M. Jaffee, Lutherville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20110243972 | PROSTATE STEM CELL ANTIGEN VACCINES AND USES THEREOF - This invention relates to the identification of prostate stem cell antigen (PSCA) as a target of clinically relevant antitumor immune responses. The invention provides vaccines comprising PSCA, or fragments thereof, which are useful in inducing antitumor immune responses, including PSCA specific CD8+ T cell responses. Methods of using the compositions to treat cancer are also provided. The invention further provides methods of identifying compounds useful in antitumor vaccines and methods of assessing the responses of patients to cancer immunotherapy. | 10-06-2011 |
Elizabeth Marion Jaffee, Lutherville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20110293608 | ANNEXIN A2 AS IMMUNOLOGICAL TARGET - AnnexinA2 (ANXA2), a member of the Annexin family of calcium-dependent, phospholipid binding proteins, is one of a panel of identified antigens recognized by the post-vaccination sera of patients who demonstrated prolonged disease-free survival following multiple vaccinations. AnnexinA2 is abundantly expressed in pancreatic adenocarcinomas and cell surface/membrane AnnexinA2 increases with the progression from premalignant lesions to invasive pancreatic adenocarcinomas. The cytoplasmic to cell surface translocation of AnnexinA2 expression is critical for pancreatic cancer cell invasion. In addition, phosphorylation of AnnexinA2 at Tyrosine 23 is important for its localization to the cell surface and for the invasion of pancreatic cancer cells. Finally, loss of AnnexinA2 leads to the loss of the Epithelial-Mesenchymal Transition. | 12-01-2011 |
James I. Jaffee, Solana Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100194206 | WIRELESS POWER FOR CHARGING DEVICES - Exemplary embodiments are directed to wireless power. A host device peripheral may comprise a wireless power charging apparatus, which may include transmit circuitry and at least one antenna coupled to the transmit circuitry. The at least one antenna may be configured to wirelessly transmit power within an associated near-field region. Additionally, the host device peripheral may be configured to couple to a host device. | 08-05-2010 |